• Intellia Therapeutics Inc. (NTLA) Stock Price | Live Quotes & Charts | NASDAQ timothysykes.com Thu, 09 Jul 2026 23:42:13 GMT
• Intellia Therapeutics (NTLA) Could Be 37% Undervalued After Phase 3 Lonvo Z Success Yahoo Finance Thu, 09 Jul 2026 18:20:44 GMT
• NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock? Yahoo Finance Thu, 09 Jul 2026 14:19:00 GMT
• Intellia Therapeutics (NTLA) Could Be 37% Below Fair Value On Gene Editing Hopes simplywall.st Thu, 09 Jul 2026 13:40:02 GMT
• Intellia Therapeutics (NTLA) Stock Looks Rich On Sales But Weak On Returns Yahoo Finance Thu, 09 Jul 2026 11:12:29 GMT
• Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57% AOL.com Thu, 09 Jul 2026 07:02:54 GMT
• (NTLA) Movement as an Input in Quant Signal Sets Stock Traders Daily Thu, 09 Jul 2026 02:06:02 GMT
• Pre-Market Movements | Intellia Therapeutics' Multiple News Items Drive Stock Price Fluctuations 富途牛牛 Wed, 08 Jul 2026 13:34:41 GMT
• A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics Yahoo Finance Wed, 08 Jul 2026 10:05:00 GMT
• Price to earnings forward of Intellia Therapeutics, Inc. – LS:A2AG6H TradingView Wed, 08 Jul 2026 03:00:34 GMT
• NTLA Stock Surges 35% Overnight: Retail Mood Peaks Ahead Of First-Ever Phase 3 Readout For Gene-Editing Therapy Stocktwits Tue, 07 Jul 2026 13:27:09 GMT
• Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dulac Edward J III Moomoo Tue, 07 Jul 2026 02:53:53 GMT
• Form 4 Intellia Therapeutics Inc For: 6 July By Investing.com Investing.com Canada Mon, 06 Jul 2026 21:11:27 GMT
• Intellia Therapeutics (NTLA) VP sells shares to cover RSU tax Stock Titan Mon, 06 Jul 2026 21:02:31 GMT
• Intellia (NTLA) CFO’s 4,677-share sale executed under 10b5-1 plan Stock Titan Mon, 06 Jul 2026 21:01:37 GMT
• Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Mon, 06 Jul 2026 20:05:00 GMT
• Intellia lures 13 new employees with 53,250 stock awards Stock Titan Mon, 06 Jul 2026 20:05:00 GMT
• ntla stock surges 35% overnight: retail mood peaks ahead of first-ever phase 3 readout for gene-editing therapy Stocktwits Sun, 05 Jul 2026 13:52:11 GMT
• ntla stock rockets after hours before critical data for genetic disorder therapy Stocktwits Sat, 04 Jul 2026 21:26:31 GMT
• wall street thinks this high-flying biotech stock can soar another 57% AOL.com Sat, 04 Jul 2026 11:54:11 GMT
• Is Intellia Therapeutics, Inc. (NTLA) A Good Stock To Buy Now? Yahoo Finance Fri, 03 Jul 2026 23:42:49 GMT
• ntla stock surges 35% overnight: retail mood peaks ahead of first-ever phase 3 readout for gene-editing therapy Stocktwits Fri, 03 Jul 2026 13:04:43 GMT
• intellia therapeutics | 144: notice of proposed sale of securities pursuant to rule 144 Moomoo Fri, 03 Jul 2026 03:03:45 GMT
• NTLA Stock Price Prediction 2025-2026 | Intellia Therapeutics Inc Forecast 24/7 Wall St. Thu, 02 Jul 2026 22:20:03 GMT
• form 144 intellia therapeutics for: 2 july by investing.com Investing.com Canada Thu, 02 Jul 2026 21:01:45 GMT
• Intellia Therapeutics (NTLA) Is Up 11.2% After Lonvo-z Phase 3 Progress And 2027 Launch Plans - Has The Bull Case Changed? simplywall.st Thu, 02 Jul 2026 15:41:18 GMT
• ntla jumps premarket on positive late-stage trial data for gene-editing therapy — retail says buy now before it’s too late Stocktwits Thu, 02 Jul 2026 14:04:33 GMT
• ntla stock rockets after hours before critical data for genetic disorder therapy Stocktwits Thu, 02 Jul 2026 11:36:35 GMT
• ntla stock news today | earnings, events & price alerts Intellectia AI Thu, 02 Jul 2026 07:10:35 GMT
• more ntla, less rklb: cathie wood’s latest ark trades explained Stocktwits Thu, 02 Jul 2026 03:57:38 GMT
• ntla stock news today | earnings, events & price alerts Intellectia AI Wed, 01 Jul 2026 21:04:17 GMT
• wall street thinks this high-flying biotech stock can soar another 57% The Motley Fool Wed, 01 Jul 2026 20:45:00 GMT
• investor sentiment divided in healthcare sector: intellia therap GuruFocus Wed, 01 Jul 2026 16:41:14 GMT
• intellia therapeutics (nasdaq:ntla): can innovation justify the buzz? Kalkine Media Wed, 01 Jul 2026 16:28:00 GMT
• Intellia Therapeutics (NTLA) Stock Looks Overvalued On Sales Despite Strong Trial Progress simplywall.st Wed, 01 Jul 2026 07:00:00 GMT
• ntla jumps premarket on positive late-stage trial data for gene-editing therapy — retail says buy now before it’s too late Stocktwits Mon, 29 Jun 2026 13:52:09 GMT
• price to book forward of intellia therapeutics, inc. – nasdaq:ntla TradingView Mon, 29 Jun 2026 03:16:12 GMT
• Price to earnings forward of Intellia Therapeutics, Inc. – DUS:38I TradingView Sun, 28 Jun 2026 23:24:39 GMT
• price to book forward of intellia therapeutics, inc. – dus:38i TradingView Sun, 28 Jun 2026 23:24:05 GMT
• enterprise value to revenue forward of intellia therapeutics, inc. – nasdaq:ntla TradingView Sun, 28 Jun 2026 17:38:07 GMT
• enterprise value to ebit forward of intellia therapeutics, inc. – nasdaq:ntla TradingView Sun, 28 Jun 2026 13:52:32 GMT
• price to sales forward of intellia therapeutics, inc. – nasdaq:ntla TradingView Sun, 28 Jun 2026 10:59:32 GMT
• enterprise value to ebitda forward of intellia therapeutics, inc. – nasdaq:ntla TradingView Sun, 28 Jun 2026 09:48:49 GMT
• ntla stock rockets after hours before critical data for genetic disorder therapy Stocktwits Sun, 28 Jun 2026 04:48:14 GMT
• certain stock options of intellia therapeutics, inc. are subject to a lock-up agreement ending on 28-jun-2026. marketscreener.com Sun, 28 Jun 2026 00:37:07 GMT
• ntla stock surges 35% overnight: retail mood peaks ahead of first-ever phase 3 readout for gene-editing therapy Stocktwits Sat, 27 Jun 2026 18:56:47 GMT
• intellia therapeutics vs. omeros: which emerging biotech stock is a better buy in 2026? AOL.com Sat, 27 Jun 2026 12:40:14 GMT
• intellia therapeutics inc (ntla) technical analysis: support, resistance, indicators & moving averages TradingKey Sat, 27 Jun 2026 04:24:19 GMT
• more ntla, less rklb: cathie wood’s latest ark trades explained Stocktwits Fri, 26 Jun 2026 14:02:22 GMT
• why is intellia therapeutics (ntla) a battleground stock with 38% short interest Kavout | AI Fri, 26 Jun 2026 11:40:27 GMT
• intellia therapeutics, inc. actuals & estimates (nasdaq:ntla) TradingView Fri, 26 Jun 2026 10:52:44 GMT
• Intellia Therapeutics Stock Short Interest Rises to 45.4% Quiver Quantitative Fri, 26 Jun 2026 07:00:00 GMT
• 3 under-the-radar biotech takeover targets for the next pharma buying spree AOL.com Thu, 25 Jun 2026 12:34:39 GMT
• impressive clinical trial data drives intellia therapeutics up 70% this year NAI500 Thu, 25 Jun 2026 08:21:36 GMT
• ntla stock news today | earnings, events & price alerts Intellectia AI Thu, 25 Jun 2026 00:47:15 GMT
• ntla stock news today | earnings, events & price alerts Intellectia AI Wed, 24 Jun 2026 19:55:45 GMT
• intellia therapeutics vs. omeros: which emerging biotech stock is a better buy in 2026? AOL.com Wed, 24 Jun 2026 17:19:49 GMT
• ntla stock rockets after hours before critical data for genetic disorder therapy Stocktwits Wed, 24 Jun 2026 15:37:12 GMT
• ntla stock surges 35% overnight: retail mood peaks ahead of first-ever phase 3 readout for gene-editing therapy Stocktwits Wed, 24 Jun 2026 10:46:53 GMT
• ntla jumps premarket on positive late-stage trial data for gene-editing therapy — retail says buy now before it’s too late Stocktwits Wed, 24 Jun 2026 10:13:57 GMT
• wall street expects this growth stock that's already climbed 70% to almost double -- and here's why. AOL.com Wed, 24 Jun 2026 08:23:00 GMT
• intellia therapeutics vs. omeros: which emerging biotech stock is a better buy in 2026? AOL.com Mon, 22 Jun 2026 09:27:10 GMT
• ntla jumps premarket on positive late-stage trial data for gene-editing therapy — retail says buy now before it’s too late Stocktwits Mon, 22 Jun 2026 01:28:48 GMT
• StockWatch: Positive Phase III Data Sells Investors on Intellia Genetic Engineering and Biotechnology News Sun, 21 Jun 2026 23:40:59 GMT
• why is intellia therapeutics (ntla) a battleground stock with 38% short interest Kavout Sun, 21 Jun 2026 22:42:58 GMT
• ntla stock news today | earnings, events & price alerts Intellectia AI Sun, 21 Jun 2026 12:16:40 GMT
• intellia therapeutics (ntla) is up 29.4% after new phase 3 lonvo-z data and fda filing simplywall.st Sun, 21 Jun 2026 07:00:00 GMT
• more ntla, less rklb: cathie wood’s latest ark trades explained Stocktwits Sun, 21 Jun 2026 06:12:27 GMT
• intellia therapeutics vs. omeros: which emerging biotech stock is a better buy in 2026? AOL.com Sun, 21 Jun 2026 03:17:06 GMT
• ntla stock rockets after hours before critical data for genetic disorder therapy Stocktwits Sun, 21 Jun 2026 00:30:16 GMT
• ntla stock news today | earnings, events & price alerts Intellectia AI Sat, 20 Jun 2026 08:23:17 GMT
• Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? The Motley Fool Sat, 20 Jun 2026 07:00:00 GMT
• ntla stock news today | earnings, events & price alerts Intellectia AI Fri, 19 Jun 2026 22:39:58 GMT
• ntla jumps premarket on positive late-stage trial data for gene-editing therapy — retail says buy now before it’s too late Stocktwits Fri, 19 Jun 2026 07:18:29 GMT
• Intellia Therapeutics (NTLA) Stock Could Be 41.2% Undervalued After Phase 3 HAE Data simplywall.st Fri, 19 Jun 2026 07:00:00 GMT
• friday five – fda flexibility, biogen's latest bolt-on, intellia's crispr case may be needle in a hae-stack…and more FirstWord Pharma Fri, 19 Jun 2026 00:08:06 GMT
• why crispr therapeutics stock has been on a roller-coaster ride this year AOL.com Thu, 18 Jun 2026 16:12:44 GMT
• strength seen in intellia therapeutics (ntla): can its 23.2% jump turn into more strength? MSN Thu, 18 Jun 2026 09:00:00 GMT
• intellia therapeutics inc (ntla) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 18:33:32 GMT
• analysts offer insights on healthcare companies: engene holdings (engn) and intellia therapeutics (ntla) The Globe and Mail Wed, 17 Jun 2026 09:45:00 GMT
• Clinical: Single CRISPR Infusion Curbs Hereditary Angioedema Attacks CRISPR Medicine News Wed, 17 Jun 2026 07:00:00 GMT
• CCORF Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Maintains Target Price $49 Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• This Stock Is Up 58% This Year. Is It too Late to Buy? The Motley Fool Wed, 17 Jun 2026 07:00:00 GMT
• Physician Views Preview: Can Intellia's lonvo-z turn CRISPR promise into HAE practice? FirstWord Pharma Wed, 17 Jun 2026 07:00:00 GMT
• intellia therapeutics (ntla) surges 12.9% amid positive market m GuruFocus Wed, 17 Jun 2026 07:00:00 GMT
• ntla stock jumps as intellia’s hae gene-editing data impresses wall street timothysykes.com Wed, 17 Jun 2026 07:00:00 GMT
• intellia therapeutics (ntla) sees 10.7% surge in stock price GuruFocus Wed, 17 Jun 2026 07:00:00 GMT
• more ntla, less rklb: cathie wood’s latest ark trades explained Stocktwits Wed, 17 Jun 2026 01:55:29 GMT
• why (ntla) price action is critical for tactical trading Stock Traders Daily Tue, 16 Jun 2026 23:46:02 GMT
• ntla maintained by canaccord genuity -- price target stays at $4 GuruFocus Tue, 16 Jun 2026 20:48:45 GMT
• why is intellia therapeutics (ntla) a battleground stock with 38% short interest Kavout Tue, 16 Jun 2026 15:25:51 GMT
• ntla jumps premarket on positive late-stage trial data for gene-editing therapy — retail says buy now before it’s too late Stocktwits Tue, 16 Jun 2026 14:16:42 GMT
• analysts conflicted on these healthcare names: incyte (incy), intellia therapeutics (ntla) and halozyme (halo) The Globe and Mail Tue, 16 Jun 2026 11:04:00 GMT
• bofa securities maintains intellia therapeutics(ntla.us) with hold rating, maintains target price $19 Moomoo Tue, 16 Jun 2026 09:39:44 GMT
• analysts’ top healthcare picks: intellia therapeutics (ntla), electrocore (ecor) The Globe and Mail Tue, 16 Jun 2026 09:12:00 GMT
• Intellia’s gene editor ‘keeps pace’ with Ionis in hereditary angioedema BioSpace Tue, 16 Jun 2026 07:00:00 GMT
• Strength Seen in Intellia Therapeutics (NTLA): Can Its 23.2% Jump Turn into More Strength? Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• ntla posts strong additional phase iii data from hae study, stock up Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• canaccord reiterates intellia stock rating on positive trial data Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• a quick look at today's ratings for intellia therapeutics(ntla.us), with a forecast between $19 to $49 Moomoo Tue, 16 Jun 2026 07:00:00 GMT
• intellia's treatment candidate shows promising results Intellectia AI Tue, 16 Jun 2026 03:17:45 GMT
• intellia therapeutics (ntla) skyrockets 23% on encouraging lonvo-z results Yahoo Finance Tue, 16 Jun 2026 02:46:00 GMT
• intellia therapeutics stock jumps as crispr therapy data put fda filing in focus TechStock² Mon, 15 Jun 2026 22:46:43 GMT
• detailed data increases investor confidence in intellia's crispr treatment for hae FirstWord Pharma Mon, 15 Jun 2026 22:02:47 GMT
• why is intellia therapeutics stock surging today? by investing.com Investing.com Canada Mon, 15 Jun 2026 21:03:11 GMT
• ntla reiterated by citizens -- price target maintained at $30 GuruFocus Mon, 15 Jun 2026 16:06:18 GMT
• goldman sachs maintains intellia therapeutics(ntla.us) with sell rating, maintains target price $9 Moomoo Mon, 15 Jun 2026 15:48:55 GMT
• ntla reiterated by wedbush -- price target maintained at $12.00 GuruFocus Mon, 15 Jun 2026 15:42:12 GMT
• intellia reports strong phase 3 results for lonvo-z, 87% fewer monthly attacks; bla rolling, u.s. launch h1 2027 TradingView Mon, 15 Jun 2026 12:53:00 GMT
• h.c. wainwright reiterates intellia stock rating on positive trial data Investing.com Mon, 15 Jun 2026 11:55:04 GMT
• td cowen maintains intellia therapeutics(ntla.us) with buy rating Moomoo Mon, 15 Jun 2026 11:31:00 GMT
• ntla reiterated by hc wainwright & co. -- price target maintained at $25 GuruFocus Mon, 15 Jun 2026 11:01:53 GMT
• intellia therapeutics (ntla) down 7.9% since last earnings report: can it rebound? MSN Mon, 15 Jun 2026 08:44:42 GMT
• the commercial launch playbook: team structure, readiness and execution BioSpace Mon, 15 Jun 2026 07:03:58 GMT
• Intellia touts ‘paradigm-shifting’ phase 3 data for one-time HAE treatment Fierce Biotech Mon, 15 Jun 2026 07:00:00 GMT
• Intellia Therapeutics (NTLA) Skyrockets 23% on Encouraging Lonvo-Z Results Yahoo Finance Mon, 15 Jun 2026 07:00:00 GMT
• Detailed readout lifts investor confidence in Intellia's CRISPR therapy for HAE FirstWord Pharma Mon, 15 Jun 2026 07:00:00 GMT
• Intellia Therapeutics jumps after additional Phase 3 HAE data and peer-reviewed publication reinforce lonvo-z outlook Quiver Quantitative Mon, 15 Jun 2026 07:00:00 GMT
• Intellia's One-Time Gene Editing Therapy Gains Ground Against Rivals In Rare Swelling Disorder Benzinga Mon, 15 Jun 2026 07:00:00 GMT
• Phase 3 HAELO data support Intellia (NTLA) lonvo-z as potential one-time therapy Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• citizens reiterates intellia stock rating on positive trial data Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• intellia therapeutics options trading jumps to 7,041 contracts Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• intellia therapeutics (ntla) reports promising phase 3 trial res GuruFocus Mon, 15 Jun 2026 00:19:01 GMT
• ntla jumps premarket on positive late-stage trial data for gene-editing therapy — retail says buy now before it’s too late Stocktwits Sun, 14 Jun 2026 22:28:51 GMT
• intellia therapeutics (ntla) reports promising phase 3 trial res GuruFocus Sun, 14 Jun 2026 21:06:32 GMT
• intellia therapeutics presents additional results from phase 3 haelo trial TipRanks Sun, 14 Jun 2026 20:55:18 GMT
• why is intellia therapeutics (ntla) a battleground stock with 38% short interest Kavout Sun, 14 Jun 2026 16:51:07 GMT
• why intellia therapeutics (ntla) is down 10.6% after advancing lonvo-z toward fda review and commercialization simplywall.st Sun, 14 Jun 2026 16:04:45 GMT
• why is intellia therapeutics (ntla) a battleground stock with 38% short interest Kavout Sat, 13 Jun 2026 13:47:26 GMT
• intellia's crispr therapy lonvo-z shows strong phase 3 results, cutting hereditary angioedema attacks by 87%. Pluang Sat, 13 Jun 2026 12:37:00 GMT
• intellia presents phase 3 results for hae gene therapy lonvo-z Investing.com Sat, 13 Jun 2026 12:03:41 GMT
• intellia therapeutics says haleo met its primary endpoint with an 87% reduction (p TradingView Sat, 13 Jun 2026 11:38:03 GMT
• Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary ... Intellia Therapeutics Sat, 13 Jun 2026 07:00:00 GMT
Intellia Therapeutics, Inc(NASDAQ:NTLA) 
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. The company's in vivo programs include NTLA-2001, which i...
Website: http://www.intelliatx.com
Founded: 2014
Full Time Employees: 270
CEO: John Leonard
Sector: Healthcare
Industry: Biotechnology